Lincoln National Corp’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Lincoln National Corp’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46,854	Closed	-$1.84M	–	1074
2023 Q2	$1.84M	Sell	46,854 -9,136	-16%	-$322K	0.04%	273
2023 Q1	$1.36M	Buy	55,990 +5,154	+10%	+$113K	0.03%	318
2022 Q4	$1.09M	Sell	50,836 -18,000	-26%	-$384K	0.02%	337
2022 Q3	$1.24M	Buy	68,836 +3	+0%	+$39	0.03%	295
2022 Q2	$662K	Hold	68,833	–	–	0.02%	420
2022 Q1	$1.16M	Hold	68,833	–	–	0.02%	324
2021 Q4	$1.15M	Buy	68,833 +3,333	+5%	+$54.6K	0.02%	315
2021 Q3	$1.06M	Buy	65,500 +36,540	+126%	+$398K	0.02%	321
2021 Q2	$183K	Buy	+28,960	New	+$187K	﹤0.01%	824

Lincoln National Corp's ISEE Position: Q3 2023 in Review

Lincoln National Corp sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 46,854 shares — an estimated $1.84M sold.

Lincoln National Corp first reported a position in ISEE in Q2 2021 and held it in 9 quarters. The position peaked at $1.84M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Lincoln National Corp reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Lincoln National Corp sold 46,854 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.84M.
Lincoln National Corp first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Lincoln National Corp's IVERIC bio, Inc. Common Stock position peaked at $1.84M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Lincoln National Corp's 13F filing for Q3 2023, filed 6 Nov 2023.